Expression and purification of SpyCatcher003-mi3

TT Tiong Kit Tan
PR Pramila Rijal
RR Rolle Rahikainen
AK Anthony H. Keeble
LS Lisa Schimanski
SH Saira Hussain
RH Ruth Harvey
JH Jack W. P. Hayes
JE Jane C. Edwards
RM Rebecca K. McLean
VM Veronica Martini
MP Miriam Pedrera
NT Nazia Thakur
CC Carina Conceicao
ID Isabelle Dietrich
HS Holly Shelton
AL Anna Ludi
GW Ginette Wilsden
CB Clare Browning
AZ Adrian K. Zagrajek
DB Dagmara Bialy
SB Sushant Bhat
PS Phoebe Stevenson-Leggett
PH Philippa Hollinghurst
MT Matthew Tully
KM Katy Moffat
CC Chris Chiu
RW Ryan Waters
AG Ashley Gray
MA Mehreen Azhar
VM Valerie Mioulet
JN Joseph Newman
AA Amin S. Asfor
AB Alison Burman
SC Sylvia Crossley
JH John A. Hammond
ET Elma Tchilian
BC Bryan Charleston
DB Dalan Bailey
TT Tobias J. Tuthill
SG Simon P. Graham
HD Helen M. E. Duyvesteyn
TM Tomas Malinauskas
JH Jiandong Huo
JT Julia A. Tree
KB Karen R. Buttigieg
RO Raymond J. Owens
MC Miles W. Carroll
RD Rodney S. Daniels
JM John W. McCauley
request Request a Protocol
ask Ask a question
Favorite

SpyCatcher003-mi3 was expressed in E. coli BL21(DE3) RIPL cells (Agilent) as previously described18. Heat-shock transformed cells were then plated on LB-Agar plates (50 µg/mL kanamycin) and incubated for 16 h at 37 °C. A single colony was picked and cultured in 10 mL starter LB culture (50 µg/mL kanamycin) for 16 h at 37 °C and shaking at 200 rpm. The preculture was diluted 1:100 into 1 L LB (50 µg/mL kanamycin and 0.8% (w/v) glucose) and cultured at 37 °C, 200 rpm until OD600 ~0.6. Protein expression was induced with isopropyl β-d-1-thiogalactopyranoside (IPTG) (420 µM) and incubated at 22 °C, 200 rpm for a further 16 h. The culture was centrifuged and the pellet was resuspended in 20 mL 25 mM Tris–HCl, 300 mM NaCl, pH 8.5 with 0.1 mg/mL lysozyme, 1 mg/mL cOmplete mini EDTA-free protease inhibitor (Merck) and 1 mM phenylmethanesulfonyl fluoride (PMSF). Cell suspension was incubated at 22 °C for 30 min on a platform shaker and sonicated on ice four times for 60 s at 50% duty-cycle using an Ultrasonic Processor (Cole-Parmer). Cell lysate was clarified at 35,000 × g for 45 min at 4 °C. The supernatant was filtered through 0.45 and 0.22 µm syringe filters (Starlab) and 170 mg ammonium sulfate was added per mL of lysate. SpyCatcher003-mi3 particles were precipitated by incubating the lysate at 4 °C for 1 h while mixing at 100 rpm. Precipitated particles were pelleted by centrifugation at 30,000 × g for 30 min at 4 °C. The collected pellet was resuspended into 8 mL TBS pH 8.5 (25 mM Tris–HCl, 150 mM NaCl). Residual ammonium sulfate was removed by dialysing for 16 h against 500-fold excess of TBS. Dialysed SpyCatcher003-mi3 was concentrated to 4 mg/mL using a Vivaspin 20 100 kDa spin concentrator (Vivaproducts) and centrifuged at 17,000 × g for 30 min at 4 °C to pellet any insoluble material. The supernatant was filtered through a 0.22 µm syringe filter. The purified SpyCatcher003-mi3 was then further purified using size-exclusion chromatography (SEC). In brief, 2.5 mL was loaded into a HiPrep Sephacryl S-400 HR 16-600 SEC column (GE Healthcare) equilibrated with TBS using an ÄKTA Pure 25 system (GE Healthcare). Proteins were separated at 1 mL/min while collecting 1 mL elution factions. The fractions containing the purified particles were identified by SDS–PAGE, pooled, and concentrated using a Vivaspin 20 100 kDa MW cut-off centrifugal concentrator. Endotoxin was removed from the SpyCatcher003-mi3 samples using Triton X-114 phase separation as previously described18. The concentration of endotoxin-depleted particles was measured using bicinchoninic acid (BCA) assay (Pierce) and particles were stored at −80 °C.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A